Quality Risk Assessment New Product Introduction: Non-Sterile Ointment / Semi-Solid Product

Quality Risk Assessment – New Product Introduction: Non-Sterile Ointment / Semi-Solid Product

Pharmapulse USA 4

Objective: Identify, assess, and control quality risks associated with the development and manufacture of a new non-sterile ointment/semi-solid pharmaceutical product.

1️⃣ Formulation Risks

  • API–excipient incompatibility
  • API solubility & dispersion
  • Particle size / agglomeration
  • Homogeneity of formulation
  • Physical/chemical instability
  • Preservative effectiveness, where applicable

2️⃣ Manufacturing Risks

  • Incorrect weighing / dispensing
  • Inadequate mixing & homogenization
  • Temperature control failure
  • Improper order of ingredient addition
  • Mixing time / speed variation
  • Air entrapment
  • Inadequate deaeration
  • Bulk hold-time risk

3️⃣ Critical Quality Attributes (CQAs)

  • Appearance & texture
  • Assay & content uniformity
  • pH, where applicable
  • Viscosity / rheology
  • Particle size
  • Spreadability
  • Drug release / diffusion
  • Microbial limits

4️⃣ Microbiological Risks

  • Raw-material microbial contamination
  • Water-system contamination
  • Equipment/environment contamination
  • Inadequate preservation
  • Excessive bulk holding time
  • Microbial proliferation during storage/use

5️⃣ Packaging Risks

  • Container–closure compatibility
  • Tube/jar leakage
  • Interaction or adsorption with packaging
  • Moisture/oxygen/light exposure
  • Proper sealing & crimping
  • Container integrity

6️⃣ Stability Risks

  • Phase separation
  • Viscosity change
  • Color/odor change
  • API degradation
  • Microbial growth
  • Temperature/humidity sensitivity
  • Inadequate shelf-life

7️⃣ GMP & Validation

  • Equipment qualification
  • Process validation
  • Cleaning validation
  • Analytical method validation
  • Hold-time studies
  • Cleaning/changeover controls
  • Data integrity & documentation

High-Risk Areas

Homogeneity • Mixing • Temperature • Viscosity • Microbial Quality • Preservation • API Stability • Packaging Compatibility • Cleaning

QRM Approach

Identify → Risk Assessment → Risk Control → Validation → Monitoring → CAPA/Continual Improvement

Key Principle:
“Control the formulation, process, microbiological quality, packaging, and stability risks to consistently deliver a safe, effective, and quality product.”